{"id":1034,"date":"2017-06-06T13:35:27","date_gmt":"2017-06-06T12:35:27","guid":{"rendered":"http:\/\/www.glycogenoses.org\/?p=1034"},"modified":"2017-06-07T12:50:44","modified_gmt":"2017-06-07T11:50:44","slug":"nouvelle-breve-de-linstitut-de-myologie-maladie-de-pompe-enzymotherapie-substitutive-taux-danticorps-neutralisants-traitement-baisse-temps","status":"publish","type":"post","link":"https:\/\/www.glycogenoses.org\/st_qlfctn\/nouvelle-breve-de-linstitut-de-myologie-maladie-de-pompe-enzymotherapie-substitutive-taux-danticorps-neutralisants-traitement-baisse-temps\/","title":{"rendered":"Nouvelle br\u00e8ve de l&rsquo;Institut de Myologie"},"content":{"rendered":"<p>Maladie de Pompe et enzymoth\u00e9rapie substitutive : le taux d\u2019anticorps neutralisants sous traitement baisse avec le temps<\/p>\n<p><a href=\"http:\/\/www.institut-myologie.org\/2017\/05\/19\/maladie-de-pompe-et-enzymotherapie-substitutive-le-taux-danticorps-neutralisants-sous-traitement-baisse-avec-le-temps\/\">Voir ici<\/a> la nouvelle br\u00e8ve r\u00e9dig\u00e9e par l&rsquo;Institut de Myologie concernant la maladie de Pompe ( Glycog\u00e9nose Type 2) et le traitement actuel par enzymoth\u00e9rapie constitutive.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Maladie de Pompe et enzymoth\u00e9rapie substitutive : le taux d\u2019anticorps neutralisants sous traitement baisse avec le temps Voir ici la nouvelle br\u00e8ve r\u00e9dig\u00e9e par l&rsquo;Institut de Myologie concernant la maladie de Pompe ( Glycog\u00e9nose Type 2) et le traitement actuel par enzymoth\u00e9rapie constitutive. &nbsp;<\/p>\n","protected":false},"author":7,"featured_media":1036,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[14],"tags":[],"_links":{"self":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1034"}],"collection":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/comments?post=1034"}],"version-history":[{"count":4,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1034\/revisions"}],"predecessor-version":[{"id":1044,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/1034\/revisions\/1044"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/media\/1036"}],"wp:attachment":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/media?parent=1034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/categories?post=1034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/tags?post=1034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}